Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge

被引:56
|
作者
van Ingen, J. [1 ,2 ]
Aarnoutse, R. [3 ]
de Vries, G. [4 ,5 ]
Boeree, M. J. [1 ]
van Soolingen, D. [1 ,2 ,6 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands
[2] Natl Inst Publ Hlth & Environm, Natl TB Reference Lab, NL-3720 BA Bilthoven, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Clin Pharm, NL-6500 HB Nijmegen, Netherlands
[4] Municipal Publ Hlth Serv, Dept TB Control, Rotterdam, Netherlands
[5] KNCV TB Fdn, The Hague, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Clin Microbiol, NL-6500 HB Nijmegen, Netherlands
关键词
tuberculosis; multidrug-resistant; rpoB protein; Mycobacterium tuberculosis; rifampicin; DOSE RIFAMPIN;
D O I
10.5588/ijtld.10.0127
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In an outbreak of multidrug-resistant tuberculosis, the outbreak strain had an Asp516Tyr rpoB gene mutation. Phenotypically, low-level rifampicin (RMP) resistance (minimum inhibitory concentration [MIC] 1-2 mg/l) was observed. Based on drug susceptibility test results, three patients were treated with 12-15 month rifabutin-based regimens and one with a 12-month RMP-based regimen. We retrospectively performed pharmacokinetic calculations to assess the potential for RMP treatment, from which we conclude that MICs for RMP up to 1 mu g/ml may be safely overcome by applying 20 mg/kg RMP doses in treatment regimens.
引用
收藏
页码:990 / 992
页数:3
相关论文
共 50 条
  • [21] Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis
    Tho, D. Q.
    Ha, D. T. M.
    Duy, P. M.
    Lan, N. T. N.
    Hoa, D. V.
    Chau, N. V. V.
    Farrar, J.
    Caws, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (11) : 1306 - 1312
  • [22] Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by in-house, reverse line blot assay
    Suresh, Naga
    Singh, Urvashi Balbir
    Arora, Jyoti
    Pande, Jitendra Nath
    Seth, Pradeep
    Samantaray, Jyotish Chandra
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 56 (02) : 133 - 140
  • [23] Molecular characterisation of isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Central Tunisia
    Ben Kahla, I.
    Marzouk, M.
    Henry, M.
    Bedotto, M.
    Cohen-Bacrie, S.
    Ben Selma, W.
    Boukadida, J.
    Drancourt, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (12) : 1685 - 1687
  • [24] Typing of Mycobacterium tuberculosis Strains Resistant to Rifampicin and Isoniazid by Molecular Biological Methods
    O. I. Skotnikova
    E. Yu. Nosova
    O. V. Markova
    O. A. Irtuganova
    V. N. Krudu
    S. S. Ginda
    O. V. Golishcheva
    M. N. Biryukova
    E. N. Strel'tsova
    O. V. Kalyanina
    V. I. Litvinov
    A. M. Moroz
    S. A. Lapa
    D. A. Gryadunov
    V. M. Mikhailovich
    Bulletin of Experimental Biology and Medicine, 2003, 136 : 273 - 275
  • [25] Typing of Mycobacterium tuberculosis strains resistant to rifampicin and isoniazid by molecular biological methods
    Skotnikova, OI
    Nosova, EY
    Markova, OV
    Irtuganova, OA
    Ginda, SS
    Golishcheva, OV
    Biryukova, MN
    Streltsova, EN
    Kalyanina, OV
    Litvinov, VI
    Moroz, AM
    Lapa, SA
    Gryadunov, DA
    Mikhailovich, VM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 136 (03) : 273 - 275
  • [26] New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia
    Varghese, Bright
    Hillemann, Andreas
    Wijayanti, Dian Rachma
    Shoukri, Mohammed
    Al-rabiah, Fahad
    Al-Omari, Ruba
    Al-Hajoj, Sahal
    INFECTION GENETICS AND EVOLUTION, 2012, 12 (03) : 549 - 556
  • [27] Functional analysis of genetic mutations in ddn and fbiA linked to delamanid resistance in rifampicin-resistant Mycobacterium tuberculosis
    Kim, Seungmo
    Lee, Seung Heon
    Kang, Gisu
    Lee, Gyeong In
    Kim, Hyeon-Su
    Yang, Jeong Seong
    Park, Youngsuk
    Hwang, Byoung Oh
    Kim, Hyejin
    TUBERCULOSIS, 2025, 152
  • [28] Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi
    Sidiq, Zeeshan
    Hanif, M.
    Chopra, K. K.
    Khanna, Ashwani
    Jadhav, Indrani
    Dwivedi, Kaushal Kumar
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2019, 3 (02): : 87 - 91
  • [29] Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Lithuania
    Bakonyte, D
    Baranauskaite, A
    Cicenaite, J
    Sosnovskaja, A
    Stakenas, P
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (08) : 936 - 938
  • [30] Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
    Tong, Enyu
    Zhou, Ying
    Liu, Zhengwei
    Zhu, Yelei
    Zhang, Mingwu
    Wu, Kunyang
    Pan, Junhang
    Jiang, Jianmin
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 6951 - 6963